Adenoviral vectors encoding erythropoietin and their use in...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/64 (2006.01) A61K 38/18 (2006.01) A61K 48/00 (2006.01) C07K 14/505 (2006.01) C12N 15/86 (2006.01)

Patent

CA 2339779

Helper dependant adenoviral vectors encoding erythropoietin (epo) provide high levels of epo to achieve a long-term therapeutically effective dosage, and allow for repeat administration to patients with disorders such as anaemia of Chronic Renal Failure (CRF), anaemias due to beta-thalassaemia, and sickle cell anaemia (SCA).

L'invention concerne des vecteurs adénoviraux dépendant des assistants, qui codent pour l'érythropoïétine et fournissent d'importantes quantités d'érythropoïétine permettant d'obtenir des dosages thérapeutiquement efficaces qui peuvent être administrés de manière répétitive aux patients souffrant de troubles tels que l'anémie due à l'insuffisance rénale chronique, les anémies de Cooley et l'anémie des cellules falciformes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Adenoviral vectors encoding erythropoietin and their use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adenoviral vectors encoding erythropoietin and their use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenoviral vectors encoding erythropoietin and their use in... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1589051

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.